Bafna Pharmaceuticals Ltd (BAFNAPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 852453, "name": "Bafna Pharma.", "stock_name": "Bafna Pharma.", "full_name": "Bafna Pharmaceuticals Ltd", "name_url": "stocks-analysis/bafna-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "349.00", "chg": 6.8, "chgp": "1.99%", "dir": 1, "prev_price": "342.20", "mcapval": "810.00 Cr", "mcap": "Micro Cap", "scripcode": 532989, "symbol": "BAFNAPH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE878I01022", "curr_date": "Sep 24, 03:30 PM", "curr_time": "07:34 AM", "last_traded_at": "Sep 24, 03:30 PM IST", "bse_nse_vol": "33.66 k", "exc_status": "Active", "traded_date": "Sep 24, 2026", "traded_date_str": "2026 09 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 349", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-of-rs349-4203705", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4203705.png", "date": "2026-09-24 10:43:26", "description": "Surging to a fresh 52-week high of Rs 349 on 24 Sep 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, rallying 17.47% over the past nine consecutive trading sessions. This micro-cap stock’s ascent stands in stark contrast to the broader market’s subdued performance, with the Sensex down nearly 1% today and languishing 3.5% above its own 52-week low." }, { "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 342.2 on Back of Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs3422-4202493", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4202493.png", "date": "2026-09-23 10:36:05", "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 342.2, Bafna Pharmaceuticals Ltd has more than tripled in value over the past year, showcasing a remarkable rally fuelled by robust technical momentum and sustained buying interest." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 335.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs3355-4201337", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4201337.png", "date": "2026-09-22 10:36:04", "description": "Surging from a 52-week low of Rs 95 to a fresh peak of Rs 335.5, Bafna Pharmaceuticals Ltd has delivered an extraordinary 132.66% return over the past year, significantly outperforming the Sensex, which declined 8.89% in the same period. This remarkable rally culminated in a new 52-week high on 22 Sep 2026, fuelled by a confluence of robust technical indicators and sustained price momentum." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 328.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs32895-4199889", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4199889.png", "date": "2026-09-21 10:36:41", "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd reached a fresh 52-week high of Rs 328.95 on 21 Sep 2026, marking a remarkable 139.5% gain over the past year. This milestone reflects a sustained rally fuelled by strong technical momentum across multiple indicators, setting the stock apart in a market where the Sensex has declined by 9.7% over the same period." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 322.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs3225-4197516", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4197516.png", "date": "2026-09-18 11:36:06", "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a new 52-week high of Rs 322.5 on 18 Sep 2026, marking a remarkable 146.47% gain over the past year. This milestone comes amid a sustained rally driven by a confluence of bullish technical indicators and strong price momentum." }, { "title": "Bafna Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4191029", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_mojoScore_4191029.png", "date": "2026-09-12 10:10:26", "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Bafna Pharmaceuticals Gains 2.13%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-213-3-key-factors-driving-the-weeks-momentum-4183634", "imagepath": "", "date": "2026-09-05 15:03:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> New 52-week high and upper circuit hit at Rs.304.50</p>\n <p><strong>1 Sep:</strong> All-time high reached at Rs.318</p>\n <p><strong>2 Sep:</strong> Price correction begins with a 2.00% decline</p>\n <p><strong>4 Sep:</strong> Week closes at Rs.296.60, down 1.97% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.290.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.296.60</div><div class=\"stat-change ..." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-of-rs318-4177406", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4177406.png", "date": "2026-09-01 09:45:39", "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4176184", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4176184.png", "date": "2026-08-31 11:00:08", "description": "At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares." } ], "total": 389, "sid": "852453", "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "11-Sep-2026", "details": "We herewith enclose the Outcome / Proceedings of the 31st Annual General Meeting of the Company held on September 11 2026.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "11-Sep-2026", "details": "We herewith enclose the Voting Results of the 31st Annual General Meeting of the Company held on September 11 2026 along with the Scrutinizer Report.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "21-Aug-2026", "details": "We herewith enclose the Newspaper Publication for the 31st Annual General Meeting of the Company published in Business Standard and Makkal Kural on August 20 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13", "dt": "2013-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

31 Aug: New 52-week high and upper circuit hit at Rs.304.50

1 Sep: All-time high reached at Rs.318

2 Sep: Price correction begins with a 2.00% decline

4 Sep: Week closes at Rs.296.60, down 1.97% on the day

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318

2026-09-01 09:45:39

From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent

2026-08-31 11:00:08

At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article